Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.themismedicare.com | |
Market Cap | 1,995.43 Cr. | |
Enterprise Value(EV) | 2,067.63 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 4.92 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 44.06 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.38 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 39.78 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.45 | Calculated using Price: 216.80 |
Dividend Yield | 0.23 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.20 Cr. | 92,040,120 Shares |
FaceValue | 1 | |
About Themis Medicare Ltd. | ||
Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary. |
1 Day |
|
+1.12% |
1 Week |
|
-4.00% |
1 Month |
|
-6.37% |
3 Month |
|
-5.82% |
6 Month |
|
+50.40% |
1 Year |
|
+43.88% |
2 Year |
|
+151.92% |
5 Year |
|
+714.93% |
10 Year |
|
+3387.10% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 9.4 | 22.85 | 13.16 | 5.42 | -8 | 9.34 | 13.09 | 28.84 | 18.16 | |
Return on Capital Employed (%) | 9.45 | 14.69 | 12.92 | 8.52 | -1.25 | 11.81 | 15.21 | 31.07 | 20.59 | |
Return on Assets (%) | 1.94 | 5.52 | 5.29 | 2.95 | -4.29 | 4.86 | 7.32 | 17.93 | 11.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 59 | 74 | 152 | 169 | 158 | 183 | 219 | 287 | 339 | 364 | |
Non Curr. Liab. | 82 | 71 | 8 | 7 | 3 | 8 | 24 | 31 | 35 | 35 | |
Curr. Liab. | 136 | 130 | 124 | 125 | 147 | 155 | 128 | 124 | 149 | 149 | |
Minority Int. | 0 | 0 | |||||||||
Equity & Liab. | 277 | 275 | 284 | 301 | 307 | 345 | 371 | 442 | 524 | 548 | |
Non Curr. Assets | 143 | 142 | 160 | 157 | 158 | 165 | 186 | 214 | 249 | 263 | |
Curr. Assets | 133 | 133 | 124 | 143 | 150 | 180 | 185 | 228 | 275 | 285 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 277 | 275 | 284 | 301 | 307 | 345 | 371 | 442 | 524 | 548 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 202 | 232 | 217 | 210 | 184 | 202 | 231 | 395 | 354 | 364 | |
Other Income | 13 | 3 | 3 | 3 | 3 | 3 | 4 | 7 | 12 | 7 | |
Total Income | 214 | 236 | 220 | 213 | 186 | 205 | 234 | 401 | 366 | 371 | |
Total Expenditure | -184 | -194 | -184 | -185 | -181 | -166 | -181 | -299 | -287 | -311 | |
PBIDT | 31 | 41 | 36 | 28 | 5 | 39 | 53 | 102 | 79 | 59 | |
Interest | -15 | -12 | -12 | -12 | -12 | -13 | -13 | -9 | -10 | -10 | |
Depreciation | -11 | -12 | -7 | -7 | -8 | -8 | -9 | -9 | -10 | -12 | |
Taxation | 1 | -2 | -2 | 0 | 2 | -2 | -6 | -22 | -16 | -10 | |
Exceptional Items | |||||||||||
PAT | 5 | 15 | 15 | 9 | -13 | 16 | 26 | 73 | 57 | 28 | |
Minority Interest | 0 | 0 | |||||||||
Share Associate | 1 | 1 | 1 | 3 | 2 | 9 | 9 | 18 | |||
Other Related Items | |||||||||||
Consolidated Net Profit | 6 | 16 | 16 | 11 | -11 | 25 | 36 | 73 | 57 | 45 | |
Adjusted EPS | 1 | 2 | 2 | 1 | -1 | 3 | 4 | 8 | 6 | 5 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | 19 | 26 | -2 | 8 | 11 | 0 | 57 | 34 | 16 | |
Cash Fr. Inv. | -7 | -6 | -7 | -4 | 0 | -4 | -5 | -16 | -16 | -24 | |
Cash Fr. Finan. | 2 | -18 | -13 | 5 | -9 | -10 | 7 | -26 | -18 | 0 | |
Net Change | 4 | -5 | 5 | 0 | -1 | -3 | 2 | 16 | 1 | -8 | |
Cash & Cash Eqvt | -35 | -40 | -34 | 6 | 4 | 2 | 3 | 19 | 20 | 13 |
Fri, 03 May 2024
Disclosure under SEBI Takeover Regulations ᅡᅠDinesh S. Patelᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ |
Fri, 03 May 2024
Board Meeting Intimation THEMIS MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
Fri, 03 May 2024
Dividend Updates Themis Medicare Limited has informed the Exchange about Dividend Updates |
Tue, 07 May 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Making Lower Lows for 3 days |
Making Lower Lows for 2 Days |